These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3454969)

  • 1. [Long-term results of treatment with oral amiodarone in patients with malignant ventricular arrhythmias].
    Grande A; Farré J
    Rev Esp Cardiol; 1987; 40(5):317-26. PubMed ID: 3454969
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation.
    Heger JJ; Prystowsky EN; Jackman WM; Naccarelli GV; Warfel KA; Rinkenberger RL; Zipes DP
    N Engl J Med; 1981 Sep; 305(10):539-45. PubMed ID: 6789201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with amiodarone for treatment of recurrent ventricular tachycardia and ventricular fibrillation.
    Heger JJ; Prystowsky EN; Miles WM; Zipes DP
    Br J Clin Pract Suppl; 1986 Apr; 44():16-27. PubMed ID: 3089256
    [No Abstract]   [Full Text] [Related]  

  • 4. [Predictive factors of induction of ventricular arrhythmia under amiodarone].
    Bourret N; Kirkorian G; Chevalier P; Bellon C; Richalet C; Bouchayer D; Bonnefoy E; Touboul P
    Arch Mal Coeur Vaiss; 1996 Oct; 89(10):1277-81. PubMed ID: 8952825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation.
    Herre JM; Sauve MJ; Malone P; Griffin JC; Helmy I; Langberg JJ; Goldberg H; Scheinman MM
    J Am Coll Cardiol; 1989 Feb; 13(2):442-9. PubMed ID: 2913120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiodarone for refractory cardiac arrhythmias: 10-year study.
    Leak D; Eydt JN
    CMAJ; 1986 Mar; 134(5):495-501. PubMed ID: 3948063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of amiodarone to prevent ventricular fibrillation (sudden death) in hypertrophic cardiomyopathy.
    Mercereau D; Kubac G; Klinke WP
    Can J Cardiol; 1989 Mar; 5(2):77-80. PubMed ID: 2706577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous amiodarone for short-term treatment of refractory ventricular tachycardia or fibrillation.
    Nalos PC; Ismail Y; Pappas JM; Nyitray W; DonMichael TA
    Am Heart J; 1991 Dec; 122(6):1629-32. PubMed ID: 1957758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prediction of long-term efficacy of amiodarone for refractory ventricular tachycardia: clinical significance of electrophysiologic study and Holter monitoring].
    Tsuchiya M; Kasanuki H; Ohnishi S; Hosoda S
    J Cardiol; 1996 Nov; 28(5):267-76. PubMed ID: 8953400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia.
    Gambhir DS; Bhargava M; Nair M; Arora R; Khalilullah M
    Indian Heart J; 1996; 48(2):133-7. PubMed ID: 8682552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Remote results of the pharmacological treatment of patients with a high risk of sudden heart arrest in ventricular disorders of cardiac rhythm].
    Popławska W; Chlewicka I; Wójcik E; Paczkowski D; Walczak F; Podleśny J
    Kardiol Pol; 1987; 30(10-11):644-52. PubMed ID: 3450944
    [No Abstract]   [Full Text] [Related]  

  • 13. The efficacy of amiodarone in the treatment of refractory nonsustained ventricular tachycardia.
    Ballas SL; Veltri EP
    Md Med J; 1991 Jun; 40(6):475-8. PubMed ID: 1861575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiodarone. Therapeutics and guidelines.
    Frei J
    Prog Cardiovasc Nurs; 1989; 4(4):113-8. PubMed ID: 2602355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
    Bokhari F; Newman D; Greene M; Korley V; Mangat I; Dorian P
    Circulation; 2004 Jul; 110(2):112-6. PubMed ID: 15238454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone in long term management of refractory cardiac tachyarrhythmias.
    Lubbe WF; Mercer CJ; Roche AH; Lowe JB
    N Z Med J; 1981 Jan; 93(676):31-5. PubMed ID: 6940024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation].
    Raviele A; Di Pede F; Delise P; Piccolo E
    G Ital Cardiol; 1984 Sep; 14(9):644-54. PubMed ID: 6510619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefit and risks of long-term amiodarone therapy for sustained ventricular tachycardia/fibrillation: minimum of three-year follow-up in 145 patients.
    Myers M; Peter T; Weiss D; Nalos PC; Gang ES; Oseran DS; Mandel WJ
    Am Heart J; 1990 Jan; 119(1):8-14. PubMed ID: 2296879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amiodarone-induced ventricular fibrillation.
    McComb JM; Logan KR; Khan MM; Geddes JS; Adgey AA
    Eur J Cardiol; 1980; 11(5):381-5. PubMed ID: 7398728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic factors after sustained ventricular fibrillation or tachycardia. A multivariate study apropos of 160 cases].
    Fleurant E; Lacroix D; Klug D; Warembourg H; Kacet S; Lekieffre J
    Arch Mal Coeur Vaiss; 1996 Apr; 89(4):435-44. PubMed ID: 8763003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.